Impact of public health insurance coverage of novel anticancer medication on medical expenditure and patient affordability in a provincial medical centre of China: a propensity score-matching analysis with the quasi-experimental design

• Hong Li,
• Jing Sun,
• Ji Huang,
• Kai Xu,
• Yifan Diao,
• Mengbo Lin,
• Xiongwei Wu,
• Mingshuang Li

Affiliations

Hong Li

Affiliated Clinical Medical Institute of Fujian Medical University, Fujian Provincial Hospital, Fuzhou, Fujian, China

Jing Sun

School of Health Policy and Management, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

Ji Huang

Affiliated Clinical Medical Institute of Fujian Medical University, Fujian Provincial Hospital, Fuzhou, Fujian, China

Kai Xu

Affiliated Clinical Medical Institute of Fujian Medical University, Fujian Provincial Hospital, Fuzhou, Fujian, China

Yifan Diao

School of Health Policy and Management, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

Mengbo Lin

Affiliated Clinical Medical Institute of Fujian Medical University, Fujian Provincial Hospital, Fuzhou, Fujian, China

Xiongwei Wu

Affiliated Clinical Medical Institute of Fujian Medical University, Fujian Provincial Hospital, Fuzhou, Fujian, China

Mingshuang Li

School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China